Pharmaceutical Excipients: Global Market Growth, Trends and Forecast 2019-2024 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical
Excipients Market – Growth, Trends, and Forecast (2019 – 2024)”
report has been added to ResearchAndMarkets.com’s
offering.

The major factors responsible for the growth of the pharmaceutical
excipients market include the increasing demand for functionality
excipients, recent patents expiries driving the demand for
pharmaceutical excipients, and rapid advancements in nanotechnology.

Many blockbuster drugs are on the verge of losing their patents. The
patent cliff (the period between 2011 and 2016) resulted in hundreds of
billions of dollars’ worth of brand drug sales losing patent protection.
Another patent cliff is expected in the coming years.

When patents expire, generic drug companies are free to create their own
replicas, and these can cost up to 80% less than the originals, which
inevitably lead to a sharp and sudden loss in sales for the companies
that developed them. Over 300 drug patents have expired in the year 2017.

The effect of patent expiration can also be seen on Roche Holdings’
major revenue generated through oncology drugs, such as Avastin,
Herceptin, and MabThera/Rituxan are about to expire/expired in 2020,
2019, and 2018, respectively. This encouraged pharmaceutical companies
to try and extend patents by using functionality excipients.

The pharmaceutical industry is being weighed down by the pressure to cut
costs, generic competition, and lack of innovation. Excipients are
becoming an important aspect in tablet manufacture as they provide
enhanced functionality to pharmaceuticals, aid in drug development and
innovation, and help improve patent life, all at a lower cost.

Key Market Trends

Binders Expected to Be the Fastest Growing Market over the Forecast
Period

In recent years, binders have made significant gains in quantities used
and revenues captured. The pharmaceutical industry has gradually
recognized binders to be able to aid active pharmaceutical ingredients
to achieve better functionality and provide a competitive advantage.

One example of enhanced micro-level demand for binders is the blooming
of extended-release formulation, which is made possible through proper
binder application. One of the most widely used modalities of binders is
the wet granulation process; it is often required when the
pharmaceutical form contains a high level of active ingredients. Major
market players, such as the Roquette Group, have manufactured multiple
pharmaceutical binders with different degrees of water solubility or
dispersibility.

Some of the examples include LYCATAB PGS – A cold water soluble starch,
ideally used in high shear equipment and LYCATAB DSH – a water-soluble
maltodextrin binder, suitable for the preparation of granulation
solutions or use in dry blends. Due to the ease of administration and
affordable price, the demand for binders is rising robustly. This
increased demand, in turn, stimulates the consumption of binders in
pharmaceutical products, and hence, is a driving factor for this segment
during the forecast period.

North America is Expected to Account for the Largest Market Share

North America is found to hold a major share for the pharmaceutical
excipients market and is expected to show a similar trend over the
forecast period. The US excipient industry is expected to evolve
closely, along with the progress of the pharmaceutical industry, as new
active pharmaceutical ingredients are developed and novel technologies
are adopted (i.e., novel drug delivery systems). Following this trend,
innovative multifunctional excipients and specialty blends can be
expected to arrive in the market during the forecast period.

In the United States, at the macro-level, the rising global demand for
pharmaceuticals has fueled the growth of drug production, and
consequently, excipient consumption. Within the pharmaceutical industry,
the downward price pressure, reduced R&D productivity, and stringent
regulations have forced drug manufacturers to increasingly turn to
excipients with the intent to develop differentiated and value adding
products at low costs without compromising quality. One example of
enhanced micro-level demand is the blooming of extended-release
formulation, which is made possible through proper excipient application.

Competitive Landscape

The market studied is fragmented, owing to the presence of a large
number of small and big companies. Some of the market players are
Ashland, BASF SE, DuPont, Roquette Freres, Evonik Industries AG,
Associated British Foods PLC, The Lubrizol Corporation, Archer Daniels
Midland Company, and Croda International PLC.

Key Topics Covered

1 INTRODUCTION
1.1 Study Deliverables
1.2
Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2
Market Drivers
4.2.1 Increasing Demand for Functionality Excipients
4.2.2
Recent Patents Expiries Driving the Demand for Pharmaceutical Excipients
4.2.3
Rapid Advancements in Nanotechnology
4.3 Market Restraints
4.3.1
Stringent Regulatory Framework
4.3.2 Decline in R&D Investments
4.4
Porter’s Five Forces Analysis

5 MARKET SEGMENTATION
5.1 By Product
5.1.1
Inorganic Chemicals
5.1.2 Organic Chemicals
5.2 By Delivery
Mode
5.2.1 Oral Formulations
5.2.2 Topical Formulations
5.2.3
Parenteral Formulations
5.2.4 Other Delivery Modes
5.3 By
Functionality
5.3.1 Fillers and Diluents
5.3.2 Binders
5.3.3
Suspension and Viscosity Agents
5.3.4 Coatings
5.3.5 Flavoring
Agents
5.3.6 Disintegrants
5.3.7 Colorants
5.3.8
Preservatives
5.3.9 Other Functionalities
5.4 Geography
5.4.1
North America
5.4.2 Europe
5.4.3 Asia-Pacific
5.4.4
Middle East & Africa
5.4.5 South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1
Ashland
6.1.2 BASF SE
6.1.3 DuPont
6.1.4 Roquette Freres
6.1.5
Evonik Industries AG
6.1.6 Associated British Foods PLC
6.1.7
The Lubrizol Corporation
6.1.8 Archer Daniels Midland Company
6.1.9
Croda International PLC

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/lmf4o6

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Pharmaceutical
Intermediates